Novo Nordisk AS (NVO)
103.16
-2.11
(-2.00%)
USD |
NYSE |
Nov 21, 15:08
Novo Nordisk Price: 103.16 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2024 | 103.43 | 105.74 | 103.00 | 105.27 | 7.092M |
| Nov 19, 2024 | 101.18 | 103.12 | 101.14 | 102.63 | 5.779M |
| Nov 18, 2024 | 100.32 | 101.00 | 99.42 | 99.81 | 8.790M |
| Nov 15, 2024 | 101.67 | 102.34 | 100.32 | 101.74 | 8.076M |
| Nov 14, 2024 | 106.83 | 107.00 | 105.00 | 105.32 | 4.467M |
| Nov 13, 2024 | 106.88 | 107.79 | 106.55 | 106.91 | 3.157M |
| Nov 12, 2024 | 106.81 | 107.61 | 105.70 | 107.06 | 5.135M |
| Nov 11, 2024 | 109.70 | 110.61 | 108.93 | 109.09 | 4.942M |
| Nov 08, 2024 | 107.15 | 107.87 | 106.42 | 107.20 | 5.223M |
| Nov 07, 2024 | 106.10 | 107.74 | 105.59 | 107.63 | 8.363M |
| Nov 06, 2024 | 108.27 | 108.75 | 105.03 | 105.36 | 12.04M |
| Nov 05, 2024 | 107.98 | 110.30 | 107.75 | 110.13 | 6.604M |
| Nov 04, 2024 | 110.19 | 110.66 | 109.44 | 109.72 | 6.215M |
| Nov 01, 2024 | 112.88 | 113.02 | 111.79 | 111.94 | 4.555M |
| Oct 31, 2024 | 110.21 | 112.16 | 109.63 | 111.95 | 8.455M |
| Oct 30, 2024 | 108.89 | 113.76 | 107.24 | 113.24 | 11.11M |
| Oct 29, 2024 | 111.62 | 113.27 | 111.15 | 111.98 | 8.243M |
| Oct 28, 2024 | 112.41 | 112.72 | 111.67 | 112.36 | 5.356M |
| Oct 25, 2024 | 113.90 | 114.19 | 113.10 | 113.38 | 4.564M |
| Oct 24, 2024 | 115.21 | 115.26 | 113.91 | 113.92 | 4.500M |
| Oct 23, 2024 | 116.33 | 116.44 | 114.95 | 115.74 | 3.221M |
| Oct 22, 2024 | 115.00 | 116.65 | 114.76 | 116.47 | 4.690M |
| Oct 21, 2024 | 117.95 | 117.96 | 116.88 | 117.33 | 3.231M |
| Oct 18, 2024 | 117.76 | 118.26 | 117.14 | 118.09 | 3.193M |
| Oct 17, 2024 | 118.59 | 119.07 | 118.12 | 118.22 | 2.998M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
24.73
Minimum
Mar 20 2020
146.91
Maximum
Jun 25 2024
66.35
Average
54.22
Median
Dec 23 2021
Price Benchmarks
| Ascendis Pharma AS | 123.04 |
| Amgen Inc | 290.40 |
| AstraZeneca PLC | 63.86 |
| Grifols SA | 8.435 |
| Viking Therapeutics Inc | 52.09 |
Price Related Metrics
| PE Ratio | 33.43 |
| PS Ratio | 11.71 |
| PEG Ratio | 1.188 |
| Price to Book Value | 25.39 |
| Price to Free Cash Flow | 46.89 |
| Earnings Yield | 2.99% |
| Market Cap | 458.36B |
| PEGY Ratio | 1.133 |
| Operating PE Ratio | 26.75 |
| Normalized PE Ratio | 33.43 |